Related Experiment Video
Updated: Aug 23, 2026

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
Advances in the management of acute and chronic decompensated heart failure
Sandra L Lowery1, Regina Massaro, Clyde W Yancy
1CCMI Associates, 1163 New Boston Road, Francestown, NH 03043, USA. ccmi@lowery.mv.com
Insights
Congestive heart failure (CHF) management faces rising hospitalizations despite improved survival. Innovative strategies are needed to reduce costs and enhance long-term stability for this chronic condition.
Area of Science:
- Cardiology
- Public Health
- Healthcare Management
Background:
- Congestive heart failure (CHF) affects millions, primarily the elderly, with significant healthcare costs.
- While mortality rates have decreased due to therapeutic advances, hospitalizations for CHF are increasing annually.
- Current hospital-based treatments for acute decompensation are insufficient for long-term patient stability.
Purpose of the Study:
- To address the challenge of minimizing treatment costs for congestive heart failure (CHF) patients.
- To enhance clinical outcomes for individuals with this prevalent chronic disease.
- To explore alternatives to traditional hospital-based acute decompensation management.
Main Methods:
- This study focuses on the challenges in managing CHF.
- It reviews current treatment paradigms for acute decompensation.
- It highlights the need for cost-effective and outcome-improving strategies.
Main Results:
- Despite advances, CHF management leads to over 1 million hospitalizations yearly.
- The annual cost exceeds $15 billion, largely impacting Medicare and Medicaid.
- Existing treatments often fail to provide long-term medical stability.
Conclusions:
- CHF poses a significant financial and clinical burden on the healthcare system.
- There is a critical need for improved case management strategies.
- Effective interventions must balance cost reduction with enhanced patient outcomes and long-term stability.
Abstract:
Congestive heart failure (CHF) is a pervasive and insidious disease that affects almost 5 million, mostly elderly, Americans. Significant therapeutic advances in the management of heart failure (HF) have resulted in striking decrements in mortality rates, but hospitalization use is ever increasing, now at over 1 million hospitalizations per year with a cost of > $15 billion--a cost that is largely borne by Medicare and Medicaid. One of the most historically challenging factors facing case managers who work with the CHF population is how to minimize treatment costs while enhancing clinical outcomes for those with this highly prevalent and clinically challenging chronic disease. To date the typical treatment of acute decompensation has been based in the hospital and woefully inadequate in promoting any long-term medical stability.
Related Concept Videos
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Heart Failure VII: Nursing Interventions
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure IV: Classification and Diagnostic Evaluation
Cardiomyopathy V: Interprofessional Care
